|

Biological: Solrikitug high dose Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Uniquity One (UNI)1

Indications

  • COPD1

Birmingham, Alabama1 trial

A Study to Evaluate Solrikitug in Participants With COPD (ZION)

University of Alabama at Birmingham Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.